White matter MRI parameters in MSON+ and MSON-.

<p>Results are reported as median (IQR). P-values were obtained from GEE model. GEE analysis was performed at eye-level. White Matter Lesion Volume: WMLV; percentage of WMLV: WMLV%; optic radiation WMLV: OR-WMLV; percentage of OR-WMLV: OR-WMLV%. Other abbreviations as in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0183957#pone.0183957.t001" target="_blank">Table 1</a>.</p

Clinical and demographic parameters of all the subjects included in the study.

<p>Clinical and demographic parameters of all the subjects included in the study.</p

Comparison of the RNFL’s sector values.

<p>Healthy Controls: HC-OCT; Not Optic Neuritis MS patients: MSON-; Optic Neuritis MS patients: MSON+; affected eye MSON+: aON+; not affected eye MS ON+: naON+.</p

Correlations between RNFL and cortical thickness.

<p>Correlations between RNFL and cortical thickness.</p

Cortical thickness values in MSON-, HC-MRI and MSON+.

<p>Cortical thickness values in MSON-, HC-MRI and MSON+.</p

sj-docx-1-tan-10.1177_17562864231177196 – Supplemental material for Alemtuzumab following natalizumab is more effective in adult-onset than paediatric-onset multiple sclerosis

Supplemental material, sj-docx-1-tan-10.1177_17562864231177196 for Alemtuzumab following natalizumab is more effective in adult-onset than paediatric-onset multiple sclerosis by Marco Puthenparampil, Marta Gaggiola, Alessandro Miscioscia, Valentina Annamaria Mauceri, Federica De Napoli, Giovanni Zanotelli, Mariagiulia Anglani, Margherita Nosadini, Stefano Sartori, Paola Perini, Francesca Rinaldi and Paolo Gallo in Therapeutic Advances in Neurological Disorders</p